SAVA

CASSAVA SCIENCES INC

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

16

Buys

13

Sells

2

Largest Trade

$1M+

Insiders

6

Institutional Funds

83

Inst. Value

$1M+

Activist Filings

9

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Anderson Robert Eugene JrDirectorBUY$15K–$50K9K$2.90Nov 25, 2025
Barry RichardPresident & CEOBUY$100K–$500K150K$2.76Nov 24, 2025
Barry RichardPresident & CEOBUY$100K–$500K73K$2.75Nov 20, 2025
Cook Robert ChristopherChief Operating & …BUY$15K–$50K14K$2.91Oct 2, 2025
Barry RichardPresident & CEOBUY$15K–$50K7K$2.28Sep 23, 2025
Barry RichardPresident & CEOBUY$500K+238K$2.25Sep 22, 2025
Kupiec James WilliamChief Medical Offi…SELL$15K–$50K4K$3.87Dec 3, 2024
Schoen EricCFOEXERCISE$50K–$100K50K$1.18Dec 3, 2024
Schoen EricCFOSELL$100K–$500K62K$3.86Dec 3, 2024
ROBERTSON SANFORDDirectorBUY$500K+30K$17.45Aug 24, 2023
Barry RichardDirectorBUY$100K–$500K18K$16.67Aug 23, 2023
Barry RichardDirectorBUY$1M+89K$25.81Mar 8, 2023
Barry RichardDirectorBUY$500K+36K$23.79Aug 25, 2022
Kupiec James WilliamChief Clinical Dev…BUY$50K–$100K3K$24.44Aug 24, 2022
Schoen EricCFOBUY$15K–$50K3K$19.95Aug 16, 2022
ROBERTSON SANFORDDirectorBUY$1M+100K$20.69Aug 16, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 83 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

The Vanguard Group

SC 13G/A · Jul 29, 2025

4.5%

2.2M shares

BlackRock, Inc.

SC 13G/A · Jul 16, 2025

3.2%

1.5M shares

Nachtrab Matthew

SC 13G/A · Nov 26, 2024

4.7%

2.3M shares

Remi Barbier

SC 13G/A · Nov 4, 2024

4.2%

2.1M shares

Nachtrab Matthew

SC 13G · Aug 21, 2024

5.4%

2.6M shares

The Vanguard Group - 23-1945930

SC 13G/A · Feb 13, 2024

5.5%

2.3M shares

Remi Barbier

SC 13G/A · Feb 1, 2024

5.7%

2.5M shares

BlackRock, Inc.

SC 13G/A · Jan 26, 2024

7.2%

3.0M shares

BlackRock, Inc.

SC 13G/A · Feb 1, 2023

6.1%

2.6M shares

View on Google Finance →